these results indicate that hyperglucagonemia following cis-ddp treatment ( 1 ) may be related to decreased glucagon degradation associated with impaired renal function and ( 2 ) does not markedly disrupt glucose homeostasis .
C0008838
cis-ddp
C0035078
impaired renal function